World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
29921
World Ranking
13116
National Ranking
6693

Overview

Angela DeMichele is affiliated with the University of Pennsylvania in the United States, with a research focus spanning medicine and biochemistry, genetics, and molecular biology. Their work prominently intersects oncology, cancer research, pulmonary and respiratory medicine, radiology, nuclear medicine, imaging, and molecular biology.

Their recent publications include studies such as "Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer" (2020, JAMA Oncology), "CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer" (2021, Nature Medicine), "Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival" (2020, Annals of Oncology), "Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial" (2021, Cancer Cell), and "Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies" (2022, Cancer Cell).

Frequent co-authors collaborating with Angela DeMichele include Christina Yau, Laura J. Esserman, Hope S. Rugo, Douglas Yee, and Laura van 't Veer.

Regular publication venues for their work include:

  • Cancer Research
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Annals of Oncology
  • npj Breast Cancer

Main areas of study comprise:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Subfields of study address:

  • Oncology
  • Cancer Research
  • Pulmonary and Respiratory Medicine
  • Radiology, Nuclear Medicine and Imaging
  • Molecular Biology

The primary research topics Angela DeMichele focuses on include:

  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Cancer Genomics and Diagnostics
  • Cancer Treatment and Pharmacology
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Immunotherapy and Biomarkers

Best Publications

  • Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

    Massimo Cristofanilli;Nicholas C. Turner;Igor Bondarenko;Jungsil Ro

  • Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer

    Nicholas C Turner;Dennis J Slamon;Jungsil Ro;Igor Bondarenko

  • ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer†

    A. Gennari;F. André;C.H. Barrios;J. Cortés

  • Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

    Lin Zhang;Stefano Volinia;Tomas Bonome;George Adrian Calin

  • A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer

    Christos Hatzis;Lajos Pusztai;Vicente Valero;Daniel J. Booser

  • Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

    Miguel Martin;Frankie A Holmes;Bent Ejlertsen;Suzette Delaloge

  • Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

    Rita Nanda;Minetta C Liu;Christina Yau;Rebecca Shatsky

  • Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

    Hope S. Rugo;Olufunmilayo I. Olopade;Angela DeMichele;Christina Yau

  • CD8 + T cells contribute to survival in patients with COVID-19 and hematologic cancer.

    Erin M Bange;Nicholas A Han;Paul Wileyto;Justin Y Kim

  • Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657

    Laura J. Esserman;Donald A. Berry;Angela DeMichele;Lisa Carey

  • Lymphedema in Breast Cancer Survivors: Incidence, Degree, Time Course, Treatment, and Symptoms

    Sandra A. Norman;A. Russell Localio;Sheryl L. Potashnik;Heather A. Simoes Torpey

  • Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma

    Reshma Rangwala;Yunyoung C. Chang;Janice Hu;Kenneth M. Algazy

  • Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer.

    Julia Tchou;Yangbing Zhao;Bruce L Levine;Paul J Zhang

  • Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI.

    Regine Choe;Alper Corlu;Kijoon Lee;Turgut Durduran

  • Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer

    Barzin Y. Nabet;Yu Qiu;Jacob E. Shabason;Tony J. Wu

  • Adaptive Randomization of Neratinib in Early Breast Cancer

    John W Park;Minetta C Liu;Douglas Yee;Christina Yau

  • Cancer Survivorship—Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations

    Lois B. Travis;Charles S. Rabkin;Linda Morris Brown;James M. Allan

  • Chemotherapy response and recurrence-free survival in Neoadjuvant breast cancer depends on biomarker profiles: Results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

    Laura J. Esserman;Donald A. Berry;Maggie C. U. Cheang;Christina Yau

  • Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer

    Keith T. Flaherty;Patricia M. LoRusso;Angela DeMichele;Vandana G. Abramson

  • Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma

    Reshma Rangwala;Robert Leone;Yunyoung C. Chang;Yunyoung C. Chang;Leslie A. Fecher

Frequent Co-Authors

Laura J. Esserman
Laura J. Esserman University of California, San Francisco
Donald A. Berry
Donald A. Berry The University of Texas MD Anderson Cancer Center
Christina Yau
Christina Yau University of California, San Francisco
Hope S. Rugo
Hope S. Rugo University of California, San Francisco
Douglas Yee
Douglas Yee University of Minnesota
Michael Feldman
Michael Feldman University of Pennsylvania
Kathy S. Albain
Kathy S. Albain Loyola University Chicago
Andrea B. Troxel
Andrea B. Troxel New York University
Laura J. van't Veer
Laura J. van't Veer University of California, San Francisco
Susan M. Domchek
Susan M. Domchek University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Medicine in the USA, numerous online degree pathways and career options are available. These programs offer flexibility for students balancing work, family, or other commitments.

If you're a registered nurse seeking career growth, bridge programs such as asn to np can help you advance to a nurse practitioner role. Similarly, you may consider online rn to bsn programs without clinical requirements to complete your degree faster and more conveniently.

Aspiring healthcare managers can enhance their leadership potential by choosing whats the best online mha program for working adults. These programs cater to busy professionals and provide the credentials valued in healthcare administration.

Those interested in nutrition and wellness can explore an online dietitian degree, opening doors to roles in clinical, community, and corporate settings.

Exploring these online options can help you tailor your education to fit your lifestyle, preparing you for diverse and in-demand healthcare careers.

Best Scientists Citing Angela DeMichele

Trending Scientists

Recently Published Articles